BioCentury
ARTICLE | Clinical News

Axiron testosterone regulatory update

June 11, 2012 7:00 AM UTC

Acrux said Australia's Therapeutic Goods Administration (TGA) approved Axiron testosterone as an androgen replacement therapy for testosterone deficiency in men. Additionally, the Pharmaceutical Benef...